Sixty-five per cent survival has been achieved in a group of patients with severe ARDS and a predicted mortality of 92%, by the use of Gattinoni's technique of extracorporeal C02 removal. In patients and animals the technique has usually resulted in rapid improvement in the radiographic appearance and lung function. There are several possible mechanisms by which the technique may facilitate lung repair, including improvement of lung tissue oxygenation, the avoidance of high airway pressures and regional alkalosis in the lung, a reduction in oxygen toxicity, and the frequently observed reduction in pulmonary artery pressure. The apparent effectiveness of the technique and other associated evidence have implications which should lead us to reconsider some aspects of our conventional management of patients with severe ARDS.
In the 1970s the technique of extracorporeal membrane oxygenation (ECMO) became popular for the support of patients with severe adult respiratory distress syndrome (ARDS), and some centres, especially in the U .S.A., became enthusiastic about its value. A multicentre randomised triaP in 1979, however, showed that although patients in the ECMO group survived on average four days longer, the overall mortality was the same in the ECMO and control groups (92070) and thus ECMO offered no advantage.
More recently, Gattinoni has introduced the technique of low frequency positive pressure ventilation and extracorporeal CO 2 removal (LFPPV and ECC02R), and his results to date are encouraging. [2] [3] [4] [5] [6] [7] [8] Superficially the technique appears similar to ECMO, but physiologically it differs in several important respects. In summary, the technique consists of the elimination of C02 through the extracorporeal circuit, using a membrane oxygenator, and insufflation of 100070 oxygen into the trachea. As there is no ventilation and no elimination of C02 through the lung, the only gas exchange which occurs in the lung is the uptake of oxygen, and oxygen is transported by mass movement from the trachea to replace that which is removed from the alveolar gas by the pulmonary blood flow. The alveolar gas composition is determined by the composition and flow of gas ventilating the oxygenator, and is identical in all ventilated alveoli, ventilation Anaesfhesia and IlIfensi\'e Carl? Vol. N, /\,'0. /, February, /986 to perfusion ratio inequality thus being eliminated. Two to three breaths per minute are supplied by the ventilator with pressure limitation to 35 cm H20, in order to provide intermittent stretching of the lung, but this is not significant in relation to C02 elimination. The technique has previously been described in detail. 5, 7, 8 Clinical experience with LFPPV-ECC0 2 R The use of LFPPV and ECC02R in patients with severe ARDS was first reported by Gattinoni in 1980. 2 He described three patients who fulfilled the multi-centre ECMO study entry criteria, I who all survived with the use of this technique. Initial reaction was, not surprisingly, guarded, However, Gattinoni has now reported the use of this technique in twenty-eight similar patients who, in addition to satisfying the ECMO study entry criteria, also had a static lung compliance of less than 30 ml cm -( H203. Twenty-one (75%) showed improvement of their respiratory failure, and fifteen (54070) were long-term survivors. This is in marked contrast to the ECMO studyl in which the majority of patients in the ECMO group died without ever showing improvement in lung function.
In his most recently published series,4 there were twelve survivors (63070) out of nineteen patients managed with LFPPV and ECC02R over an eighteen-month period. There were 36 patients in total in this period who met the ECMO study entry criteria, but sixteen of these (44070) survived without LFPPV and ECC02R, using CPAP or ventilation with reversed I:E ratio, Gattinoni states that there was a marked improvement in gas exchange following the institution of these ventilatory modes, and attributes the favourable outcome to this management. However, one must question 44070 survival in a group of patients comparable to the ECMO study group, achieved simply by using CP AP instead of CPPV, The patients were not matched for age, disease process, or duration of respiratory failure with those in the ECMO study and these results raise the possibility that Gattinoni's patient population may overall have had a less severe or prolonged underlying disease process. It is likely that mortality in ARDS is influenced by many factors other than gas exchange, and indeed Gattinoni's finding that patients who survived with continuous positive airway pressure (CP AP) or reversed I:E ratio mostly had a static lung compliance greater than 30 ml cm-( H20 suggests that compliance may be one such factor. Other recent work,9 however, does support the view that reversed I:E ratio ventilation may be beneficial in these patients (see below).
It does seem though that the remaining patients who were treated with LFPPV and ECC0 2 R, and who had a static compliance of under 25 ml cm -(, would be expected to have a mortality at least as high as those in the ECMO study, and possibly higher, with conventional management. The 63070 survival achieved using the ECC02R technique must therefore strongly suggest a beneficial effect.
A frequent observation in patients with ARDS managed with this technique has been the rapid reduction in pulmonary artery (P A) pressure within hours of starting perfusion, most of the patients having had severe pulmonary hypertension initially. There has also been rapid improvement in chest X-ray appearance over the first few days. 2,5,6 This also occurred in animal studies conducted by Gattinoni.lo, 11 In one study on foetal lambs of 128-130 days gestation, which usually died from progressive hyaline membrane disease with conventional management, the use of LFPPV and ECC02R consistently allowed the animals to be weaned to IPPV and then spontaneous breathing, after only six to twelve hours, during which time the X-rays and compliance progressively improved. 10 Cardiac output and glomerular filtration rate have frequently been shown to increase following commencement of the technique, and an increase in urine output often occurs. 12·14
Possible beneficial mechanisms 1. A voidance of lung tissue ischaemia and alkalosis
If the technique does facilitate lung repair, what is the mechanism of this effect? One clear difference from the technique used in the ECMO study! is the use of veno-venous instead of veno-arterial bypass. This avoids the reduction in pulmonary blood flow of around 30% caused by the latter technique, I and in addition allows perfusion of the lungs with blood which is more fully oxygenated. The frequent finding of large areas of ischaemic necrosis of lung tissue reported by Hill,15 in patients who died following treatment with ECMO, strongly suggests that the reduction in pulmonary blood flow resulted in lung tissue ischaemia, and perhaps in nutritional deficiencies also. 15 ,16 Major ischaemic necrosis was not seen in patients managed without ECMO. Thus it seems that whereas normal lungs show no ill effects following several hours with no pulmonary blood flow, these severely damaged lungs appear to be very dependent on an adequate pulmonary blood flow to maintain tissue viability. In addition, it has been shown that the oxygen requirement of lung tissue in severe ARDS may be considerably increased. 15 High positive airway pressures associated with artificial ventilation in severe ARDS cause many physiologic disturbances, such as reduction of cardiac output and pulmonary blood flow, and these flows may increase following the institution of ECC02R.12,17 In addition, high airway pressures may cause redistribution of pulmonary blood flow away from well ventilated areas, producing further regional ischaemia, and areas of high V IQ ratio and alkalosis, which may be harmful. 12,16,18
A voidance of high airway pressures
The other major difference from conventional ECMO is that with this technique the patients are essentially apnoeic, the total C02 production being removed by the extracorporeal circuit. Two to three breaths per minute are provided by the ventilator, with pressure limited to 35 or 40 cm H20.8 Thus high inflation pressures are avoided, and indeed Gattinoni's philosophy has been to achieve lung 'rest' in order to optimise healing. 2 ,11 There is in fact a certain amount of evidence that high inflation pressures produced by IPPV in a damaged lung may exacerbate lung damage. Bryan 19 showed in a rabbit model with surfactant depletion produced by saline lavage, that animals managed with IPPV developed marked hyaline membranes and all died by 20 hours. In contrast, animals managed with high frequency ventilation, with much lower peak airway pressures, showed little evidence of hyaline membrane formation, and four out of five survived to 20 hours, one dying of a pneumothorax. Bryan has noted the similarity between HFPPV and Gattinoni's technique, in that both avoid high airway pressures and regional overdistension of the lung. 19 Lachmann,9 using the same surfactant washout model in rabbits, investigated the effect of different ventilatory patterns on gas exchange and lung morphology. He found that airway oedema and hyaline membranes were very much more prominent following conventional ventilation than in animals ventilated with pressure limitation and prolonged inspiration (I:E ratio 4: 1). Oxygenation was also improved with reverse I:E ratio ventilation. These findings agree with Gattinoni's observations in patients with severe ARDS,4 that the use of reverse I:E ratio appeared to improve gas exchange and resolution of the ARDS. Lachmann has previously demonstrated that this model of surfactant deficiency does not itself induce alveolar or bronchiolar damage,20 and thus the hyaline membranes and epithelial desquamation can be attributed to the ventilatory management. 20-22
Gattinoni's study on premature foetal lambs lO showed that LFPPV and ECC02R allowed gradual expansion of the lungs so that the animals could be weaned on to IPPV without hyaline membrane formation. The control animals managed without ECC02R all developed severe hyaline membrane formation during IPPV, and seven out of eleven died. The period of perfusion required was often as short as eight to twelve hours, and this is clearly insufficient time for surfactant maturation, and indeed surfactant washout studies confirmed this. Thus there appears to be a specific beneficial effect of ECC02R compared with conventional IPPV in this situation, and the lower airway pressure is one likely mechanism.
Other studies have also implicated high inflation pressures in the production or exacerbation of lung damage, including several studies suggesting a causal relationship between high inflation pressure in neonatal RDS and bronchopulmonary dysplasia. 23 -34 The mechanism by which high inflation pressures may increase lung damage is not . clear, but there is evidence that high inflation pressures in ARDS cause distension of alveolar ducts and respiratory bronchioles. 27 ,34 In normal lungs, surface tension forces increase as alveolar size increases due to the greater surface area for distribution of surfactant. In surfactant deficiency states, however, this effect is much less pronounced, so alveolar instability occurs, with a tendency for small alveoli to empty into larger alveoli, due to the greater pressure in small alveoli according to Laplace's law. 9 This results in areas of atelectasis alternating with areas of overdistension, and the overdistension may be exaggerated by high inflation pressures during artificial ventilation, resulting in high shear forces. 35 This may cause epithelial disruption, and this in turn may lead to the formation of hyaline membranes.27.31. 33 The proteinaceous exudates forming the hyaline membranes contain fibrin, and there is evidence that fibrin, and probably many other mediators, stimulate fibroblast proliferation and collagen formation. 36 . 37 Fibrosis centred around alveolar ducts appears to be very common in ARDS. 36 Very little is known about the factors regulating the development of fibrosis in ARDS however. 38 In discussing the possible beneficial effects of positive end expiratory pressure (PEEP) used prophylactically in patients with normal lungs at risk 'of developing ARDS, Rinald0 39 has recently stressed our lack of knowledge of the possible effects of PEEP on pulmonary interstitial inflammation and fibrosis. Our knowledge of the possible harmful effects of the very high airway pressures required in severe ARDS on inflammation and fibrosis is equally lacking. As discussed above, however, there is considerable evidence that high inflation pressures in the severely damaged lung may produce dilatation of alveoli, alveolar ducts and respiratory bronchioles; hyaline membranes, and possibly fibrosis may ultimately result.
It has also been suggested that high airway pressures may increase lung water 40 either by interfering with pulmonary lymphatic drainage, by increasing filtration from pulmonary extraalveolar vessels,41 or by increasing left atrial pressure 42 ,43 (see below). Removal of the high inflation pressures may thus aid in the reversal of all of these processes.
Reduction of pulmonary artery pressure
The reason for the rapid fall in pulmonary artery (P A) pressures with Gattinoni' s technique is not apparent, but it has been a frequent feature.2,5 Ironically one of the .4naesrilesta and Inrensi\'e Core. ).'01. N, So. /, Febnwry, 1986 reasons for using veno-arterial bypass during ECMO was to reduce pulmonary blood flow and thus possibly to reduce P A pressure and intrapulmonary shunt, but in fact a reduction of PA pressure was often not achieved. 44 Gattinoni's technique frequently achieves this without a reduction in pulmonary blood flow. The reduced P A pressure should result in a reduction in microvascular pressure, and this may be one of the mechanisms allowing resolution of the pulmonary oedema and improvement of radiographic appearance. In addition, pulmonary hypertension in ARDS is known to result in increased right ventricular volume, causing displacement of the interventricular septum towards the left ventricle. This in turn results in reduced left ventricular compliance and elevated left ventricular end diastolic and left atrial pressures. 42 ,43,45 High airway pressures can increase this effect, resulting in further elevation of left atrial pressure and possibly reduction of cardiac output, which may be wrongly interpreted as impairment of left ventricular function. 46 . 48 Although the raised airway pressure may cause improvement in gas exchange, this elevation of left atrial pressure as well as the other consequences already described may be detrimental in the long term. Removal of the high airway pressures and reduction of P A pressure following institution of ECC02R should both reduce these various effects.
Correction of VIQ ratio
One of the fascinating features of the technique is that it renders the alveolar gas composition equal in all ventilated alveoli, by eliminating ventilationlperfusion CV IQ) inequality.7,11 Thus high V/Q lung units, which occur in overventilated areas of lung with conventional management, resulting in regional alkalosis as described previously, are avoided. Gattinoni has attributed the beneficial effects of the technique in part to this fact. 16, 18 He has shown in lambs undergoing total veno-arterial bypass, that ventilation with air consistently resulted in severe pulmonary infarction, and that these changes were almost completely avoided by using 5OJo C02 in the ventilating gas. 18
Correction of V IQ inequality with LFPPV-ECC02R also allows a lower concentration of oxygen to be used, thus reducing oxygen toxicity. There is now clear evidence that raised oxygen concentrations are toxic in acute lung injury, and that oxygen can exacerbate lung damage in concentrations which are non-toxic to the uninjured lung. 49 -50
Heparin
One obvious factor of potential benefit is the use of heparin associated with the technique. Many studies have implicated intravascular coagulation and fibrin deposition in the lung in the aetiology of ARDS,51-53 and pulmonary intravascular thrombosis has been demonstrated to be a frequent occurrence. 54, 55 However there has been no evidence of clinical benefit from the use of anticoagulants in ARDS56,57 and in the multi-centre ECMO triaJi the mortality was unchanged in the heparinised ECMO group. Thus it appears unlikely that heparin can explain the improvement seen with the use of LFPPV -ECC02R.
Complications
Bleeding has been the major complication of this technique, and has occurred primarily from surgical incision sites. The blood loss in the patients managed by Gattinoni has averaged one litre per day, including blood sampling for laboratory investigations. 12 ,58 Anticoagulation is required to prevent occlusion of the membrane oxygenators and disseminated intravascular coagulation. Recently, however, Gattinoni has had satisfactory results with lower rates of heparin infusion than those he used originally, and those used by Hill, 59 and he has found a reca1cified activated clotting time of twice normal to be satisfactory. Anticoagulation and haematological changes during ECC02R have recently been discussed. 8 ,12,58 Other complications have been very uncommon. Septicaemia, surprisingly, was less common in patients managed by ECC02R than in those managed conventionally. 3, 12 
Future developments
The technique of extracorporeal C02 removal may be considerably simplified in the future by using the technique of alkali (NaOH) infusion to neutralise hydrogen ions, and dialysis to remove bicarbonate and sodium. This can be achieved with a much lower blood flow and less complex circuitry, and has successfully been tested in animals, but not yet in humans. 6o . A pumpless circuit for CO 2 elimination has been tested in a sheep using an arterio-venous fistula and a membrane oxygenator. 61 This gave very satisfactory results, and required no supervision, and it was suggested that this may further simplify the management of this technique. It does require arterial cannulation however, and has not been tested in humans. The A-V fistula might cause difficulty in some sick patients with limitation of their cardiac output.
Implications for the conventional therapy of ARDS
Gattinoni's philosophy is that in the majority of cases severe ARDS is potentially reversible, and that it may be our therapy which perpetuates the processes. 16 ,18 Indeed, perhaps one of the most important consequences if the technique is ultimately proven to be beneficial should be that we reappraise our conventional management of severe ARDS. The finding of lung necrosis associated with reduced pulmonary blood flow by Hill l5 lends support to the concept of maintaining blood volume and cardiac output as advocated by several authors 62 ,63 rather than using aggressive dehydration therapy. Such therapy may occasionally cause a temporary improvement in gas exchange, but has never been shown to improve survival. If high inflation pressures and regional alkalosis are detrimental, we must question whether low tidal volumes with pressure limitation should be used in these patients with low lung compliance, or CPAP or reversed I:E ratio as advocated by Gattinoni, accepting some elevation of PaC02 if necessary. The acceptance of high levels of PEEP, or even 'best PEEP', simply because it improves oxygenation, may not be optimal in allowing lung repair in the long term. If high airway pressures as well as high oxygen concentrations are demonstrated to be harmful in these severely affected patients, we may have to reconsider the levels of P a o 2 which we are prepared to accept. There is some evidence that hypoxia itself may potentiate lung damage in some circumstances however, 64 These comments relate to patients with very severe ARDS and low lung compliance requiring high inflation pressures. They are not intended to apply to patients with less severe lung injury or to patients with normal lungs who are at risk of developing ARDS in whom there is some evidence that the use of IPPV and PEEP may be beneficial, and may reduce the probability of ARDS occurring. 39 ,57,65-68 While there is good evidence that artificial ventilation may be detrimental in severely damaged lungs, this is not the case, and indeed it may actually be therapeutic, in patients with normal lungs or minimal lung damage following certain insults.
CONCLUSIONS
Clearly we are a long way from understanding the cause of the inexorable progressive deterioration seen in some patients, even after correction of the underlying cause of their ARDS, and the possible beneficial effects of LFPPV and ECC02R. No studies have adequately addressed the question of which ventilatory patterns, if any, allow optimal conditions for the resolution of ARDS in the long-term, though very many studies have investigated the short-term effects on gas exchange. This technique does appear to modify the course of the disease process in these severely affected patients, and deserves more thorough and widespread appraisal. It is probable that a multi-centre controlled trial will eventually be required to determine adequately whether this technique does reduce mortality in severe ARDS.
